Gqg Partners LLC Eli Lilly & CO Transaction History

Gqg Partners LLC

$63.6 Billion
Q3 2024

A detailed history of Gqg Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gqg Partners LLC holds 4,810,840 shares of LLY stock, worth $3.75 Billion. This represents 6.7% of its overall portfolio holdings.

Number of Shares

4,810,840

Previous 4,007,699 20.04%

Holding current value

$3.75 Billion

Previous $3.63 Billion 17.46%

% of portfolio

6.7%

Previous 5.52%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $620 Million - $771 Million	803,141 Added 20.04%	4,810,840 $4.26 Billion
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $115 Million - $144 Million	158,813 Added 4.13%	4,007,699 $3.63 Billion
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $384 Million - $513 Million	648,094 Added 20.25%	3,848,886 $2.99 Billion
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $35.3 Million - $41.6 Million	-67,235 Reduced 2.06%	3,200,792 $1.87 Billion
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $51.7 Million - $71.2 Million	118,821 Added 3.77%	3,268,027 $1.76 Billion
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $60.5 Million - $80.9 Million	172,407 Added 5.79%	3,149,206 $1.48 Billion
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $413 Million - $485 Million	1,329,081 Added 80.66%	2,976,799 $1.02 Billion
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $17.1 Million - $20 Million	53,270 Added 3.34%	1,647,718 $603 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $11 Million - $12.5 Million	-37,001 Reduced 2.27%	1,594,448 $515 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $17.8 Million - $20.9 Million	-63,772 Reduced 3.76%	1,631,449 $529 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $6.93 Million - $8.61 Million	29,522 Added 1.77%	1,695,221 $485 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $7.63 Million - $9.47 Million	33,940 Added 2.08%	1,665,699 $460 Million
Q3 2021 Nov 16, 2021	SELL	$221.6 - $272.71 $16.2 Million - $19.9 Million	-72,978 Reduced 4.28%	1,631,759 $377 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $54 Million - $69.9 Million	-299,105 Reduced 14.93%	1,704,737 $391 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $9.87 Million - $12.8 Million	-60,037 Reduced 2.91%	2,003,842 $374 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $193 Million - $255 Million	1,476,146 Added 251.16%	2,063,879 $348 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $85.9 Million - $99.4 Million	587,733 New	587,733 $87 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gqg Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gqg Partners LLC with notifications on news.

Account